日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Gadd45g insufficiency drives the pathogenesis of myeloproliferative neoplasms

Gadd45g 不足导致骨髓增生性肿瘤的发病机制

Peiwen Zhang #, Na You #, Yiyi Ding, Wenqi Zhu, Nan Wang, Yueqiao Xie, Wanling Huang, Qian Ren, Tiejun Qin, Rongfeng Fu, Lei Zhang, Zhijian Xiao, Tao Cheng, Xiaotong Ma

Multi-omics analysis of human mesenchymal stem cells shows cell aging that alters immunomodulatory activity through the downregulation of PD-L1

对人类间充质干细胞的多组学分析表明,细胞衰老会通过下调PD-L1来改变免疫调节活性。

Yuchen Gao # ,Ying Chi # ,Yunfei Chen # ,Wentian Wang # ,Huiyuan Li ,Wenting Zheng ,Ping Zhu ,Jinying An ,Yanan Duan ,Ting Sun ,Xiaofan Liu ,Feng Xue ,Wei Liu ,Rongfeng Fu ,Zhibo Han ,Yingchi Zhang ,Renchi Yang ,Tao Cheng ,Jun Wei ,Lei Zhang ,Xiaomin Zhang

Hematopoietic stem cell heterogeneity is linked to the initiation and therapeutic response of myeloproliferative neoplasms

造血干细胞异质性与骨髓增生性肿瘤的发生和治疗反应有关。

Jingyuan Tong, Ting Sun, Shihui Ma, Yanhong Zhao, Mankai Ju, Yuchen Gao, Ping Zhu, Puwen Tan, Rongfeng Fu, Anqi Zhang, Ding Wang, Di Wang, Zhijian Xiao, Jiaxi Zhou, Renchi Yang, Stephen J Loughran, Juan Li, Anthony R Green, Emery H Bresnick, Dong Wang, Tao Cheng, Lei Zhang, Lihong Shi

Hematopoietic Stem Cell Heterogeneity Is Linked to the Initiation and Therapeutic Response of Myeloproliferative Neoplasms

造血干细胞异质性与骨髓增生性肿瘤的发生和治疗反应相关

Jingyuan Tong, Ting Sun, Shihui Ma, Yanhong Zhao, Mankai Ju, Yuchen Gao, Ping Zhu, Puwen Tan, Rongfeng Fu, Anqi Zhang, Ding Wang, Di Wang, Zhijian Xiao, Jiaxi Zhou, Renchi Yang, Stephen J Loughran, Juan Li, Anthony R Green, Emery H Bresnick, Dong Wang, Tao Cheng, Lei Zhang, Lihong Shi

Multilevel defects in the hematopoietic niche in essential thrombocythemia

原发性血小板增多症的造血微环境多层次缺陷

Ting Sun, Mankai Ju, Xinyue Dai, Huan Dong, Wenjing Gu, Yuchen Gao, Rongfeng Fu, Xiaofan Liu, Yueting Huang, Wei Liu, Ying Ch, Wentian Wang, Huiyuan Li, Yuan Zhou, Lihong Shi, Renchi Yang, Lei Zhang

Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system

利用 CRISPR-Cas9 系统对来自血友病 B 患者的人类诱导性多能干细胞进行靶向基因组工程

Cuicui Lyu, Jun Shen, Rui Wang, Haihui Gu, Jianping Zhang, Feng Xue, Xiaofan Liu, Wei Liu, Rongfeng Fu, Liyan Zhang, Huiyuan Li, Xiaobing Zhang, Tao Cheng, Renchi Yang, Lei Zhang